aptam
promis
role
field
life
scienc
extens
research
applic
analyt
tool
therapeut
agent
vehicl
target
drug
deliveri
compar
rna
aptam
dna
aptam
inher
advantag
stabil
facil
gener
synthesi
better
understand
specif
potenti
dna
aptam
overview
progress
gener
applic
dna
aptam
human
diseas
diagnosi
therapi
present
review
special
attent
given
research
rel
close
practic
applic
dna
aptam
expect
great
potenti
diagnosi
treatment
human
diseas
aptam
broadli
defin
short
biomolecul
like
oligonucleotid
peptid
bind
specif
target
extrem
high
affin
base
structur
conform
sinc
earli
systemat
evolut
ligand
exponenti
enrich
selex
similar
method
report
effici
select
rna
dna
aptam
thereaft
nucleic
acid
aptam
extens
research
appli
nucleic
acid
aptam
rna
singlestrand
ss
dna
oligonucleotid
length
typic
rang
mer
level
targetbind
affin
monoclon
antibodi
dissoci
constant
k
usual
rang
nm
compar
antibodi
nucleic
acid
aptam
mani
advantag
suitabl
clinic
applic
industri
includ
almost
immunogen
effici
penetr
less
batch
variat
easi
modif
costeffect
short
product
time
past
year
much
progress
made
use
nucleic
acid
aptam
particularli
rna
aptam
therapeut
agent
diagnost
analyt
tool
vehicl
target
drug
deliveri
biosensor
even
genet
control
devic
although
one
aptam
macugen
pfizereyetech
approv
therapeut
use
clinic
ten
aptam
evalu
differ
stage
clinic
trial
current
applic
diagnost
research
develop
expect
account
largest
share
aptam
market
global
aptam
market
estim
valu
million
reach
million
dna
aptam
expect
account
largest
share
global
market
indic
increas
applic
dna
aptam
dna
rna
aptam
function
similar
differ
stabil
access
compar
dna
aptam
rna
aptam
chemic
unstabl
presenc
reactiv
hydroxyl
group
oh
posit
ribos
sugar
rna
nucleotid
oh
group
easili
get
deproton
solut
especi
alkalin
solut
result
anion
nucleophil
attack
phosphoru
atom
phosphodiest
linkag
lead
hydrolysi
rna
molecul
nucleas
resist
rna
aptam
found
increas
hydroxyl
group
remov
sugar
rna
dna
aptam
less
reactiv
rel
stabl
ch
bond
posit
deoxyribos
sugar
dna
nucleotid
chemic
differ
give
dna
aptam
inher
advantag
stabil
rna
aptam
previou
studi
also
confirm
dna
aptam
much
stabl
natur
rna
aptam
fetal
bovin
serum
fb
human
serum
reason
extra
chemic
modif
usual
ad
rna
aptam
improv
chemic
stabil
howev
note
reactiv
rna
nucleotid
nonwatsoncrick
base
pair
make
rna
oligonucleotid
prone
form
divers
complex
threedimension
structur
help
select
aptam
high
affin
specif
rna
librari
therefor
dna
aptam
usual
select
librari
contain
longer
random
region
purpos
obtain
complic
structur
anoth
potenti
advantag
dna
aptam
rna
aptam
rel
simpl
select
process
select
rna
aptam
requir
revers
transcript
vitro
transcript
everi
round
select
well
initi
transcript
gener
rna
librari
dna
librari
case
select
process
dna
aptam
requir
extra
step
moreov
select
cost
produc
dna
aptam
lower
rna
aptam
sinc
first
ssdna
aptam
select
human
thrombin
dna
aptam
research
appli
variou
field
especi
diagnosi
treatment
human
diseas
dna
aptam
usual
explain
work
similar
way
rna
aptam
potenti
advantag
describ
dna
aptam
gain
increas
attent
recent
year
howev
seldom
review
systemat
independ
better
understand
uniqu
potenti
dna
aptam
articl
review
recent
progress
dna
aptam
regard
prepar
applic
diagnosi
treatment
human
diseas
advantag
remain
challeng
develop
use
dnaaptamerbas
diagnost
tool
therapeut
also
discuss
selex
interact
vitro
select
procedur
basic
method
use
engin
aptam
first
report
screen
rna
aptam
independ
ellington
tuerk
group
year
ago
selex
adapt
gener
dna
aptam
principl
aptam
select
initi
random
ssdna
pool
base
bind
oligonucleotid
target
molecul
optim
condit
ssdna
pool
contain
random
sequenc
synthet
dna
typic
length
nucleotid
flank
two
constant
region
primer
site
polymeras
chain
reaction
pcr
amplif
unbound
sequenc
separ
bound
molecul
targetbound
sequenc
amplifi
pcr
amplifi
product
doubl
strand
dna
convert
ssdna
variou
way
use
new
aptam
pool
next
select
round
enrich
aptam
sequenc
final
clone
identifi
sequenc
usual
round
select
specif
aptam
strongest
affin
target
molecul
obtain
select
aptam
use
convent
vitro
selex
requir
purifi
solubl
target
protein
process
use
obtain
purifi
protein
target
timeconsum
sometim
difficult
purifi
target
protein
moreov
sometim
aptam
select
use
nonn
protein
interact
protein
nativ
conform
solv
problem
strategi
use
whole
live
cell
target
aptam
select
develop
known
cellselex
selex
abl
gener
dna
aptam
recogn
cellsurfac
intracellular
target
protein
nativ
conform
show
great
potenti
cellspecif
therapeut
diagnost
applic
method
first
select
specif
aptam
bind
target
cell
posit
select
step
elimin
nontarget
cellspecif
aptam
neg
select
step
use
nontarget
cell
follow
selex
process
summar
figur
recent
modifi
cellselex
method
develop
select
aptam
target
specif
cell
like
diseas
state
cell
metastat
cell
stimulusrespons
cellselex
metastaticcellbas
selex
shorten
time
convent
cellselex
twostep
stimulusrespons
cellselex
method
develop
util
asymmetr
pcr
streptavidinbiotin
magnet
separ
gener
singlestrand
dna
reduc
select
cycl
two
step
competit
cellselex
anoth
approach
improv
select
effici
affin
util
nitrocellulos
membran
contain
target
cell
neg
control
cell
select
target
aptam
method
reduc
select
time
sinc
neg
select
step
requir
convent
selex
procedur
timeconsum
requir
sever
step
obtain
specif
dna
aptam
effect
gener
highli
specif
aptam
sever
novel
method
use
differ
select
approach
develop
combin
selex
method
one
effect
way
improv
select
effici
bind
affin
dna
aptam
exampl
cellselex
coupl
silico
matur
develop
improv
aptam
specif
method
consist
cellselex
postselex
silico
process
vitro
screen
normal
cellselex
extra
silico
process
perform
evolv
improv
aptam
selexselect
sequenc
success
round
sequenc
shuffl
random
mutat
base
genet
algorithm
follow
vitro
function
screen
select
enhanc
aptam
shuffl
mutat
sequenc
method
permit
evolut
function
enhanc
aptam
sequenc
recogn
target
interest
addit
selexlik
method
method
also
develop
magneticassist
rapid
aptam
select
mara
method
use
magnet
bead
extern
appli
rotat
magnet
field
provid
competit
mechan
rapid
select
aptam
differ
affin
molecular
target
summar
figur
method
use
biofunction
magnet
nanoparticl
separ
targetbound
dna
oligonucleotid
librari
select
interact
surviv
disrupt
forc
gener
movement
particl
extern
appli
rotat
magnet
field
abandon
multicycl
evolutionari
process
use
convent
selex
thu
achiev
rapid
select
complet
less
one
hour
onestep
select
approach
anoth
promis
way
increas
rate
aptam
gener
recent
rapid
onestep
select
method
develop
select
specif
dna
aptam
use
one
pcr
step
summar
figur
method
target
immobil
glass
coverslip
subject
carboxyfluorescein
fam
label
nucleic
acid
pool
bind
extens
wash
microscopi
examin
follow
pcr
enrich
select
aptam
control
experi
use
label
target
label
dna
librari
use
make
sure
specif
select
overlay
imag
immobil
target
label
alexa
fluor
red
color
target
bound
famlabel
dna
aptam
green
fluoresc
orang
color
observ
targetspecif
select
although
bind
affin
aptam
select
current
version
onestep
method
low
micromolar
rang
believ
improv
use
larger
target
increas
stringenc
select
combin
capillari
electrophoresi
separ
method
describ
userfriendli
lowcost
easi
way
select
dna
aptam
particular
method
allow
use
chemic
modifi
nucleic
acid
librari
directli
requir
one
pcr
step
moreov
dna
microarray
util
achiev
onestep
aptam
identif
sequenc
interest
produc
array
select
pcr
clone
sequenc
requir
molecul
pagepag
select
current
version
onestep
method
low
micromolar
rang
believ
improv
use
larger
target
increas
stringenc
select
combin
capillari
electrophoresi
separ
method
describ
userfriendli
lowcost
easi
way
select
dna
aptam
particular
method
allow
use
chemic
modifi
nucleic
acid
librari
directli
requir
one
pcr
step
moreov
dna
microarray
util
achiev
onestep
aptam
identif
sequenc
interest
produc
array
select
pcr
clone
sequenc
requir
targetco
magnet
bead
incub
ssdna
pool
bead
bound
sequenc
separ
unbound
sequenc
ushap
magnet
magnet
stand
redispers
bead
put
extern
appli
rotat
altern
magnet
field
process
weak
nonspecif
bind
sequenc
releas
separ
strongbind
sequenc
final
releas
bead
heat
incub
bead
without
target
neg
select
select
sequenc
amplifi
clone
sequenc
usual
c
onestep
select
famlabel
oligonucleotid
librari
incub
target
immobil
glass
coverslip
coat
nhydroxysuccinimid
nh
function
polyethylen
glycol
peg
unbound
sequenc
discard
extens
wash
follow
monitor
fluoresc
microscopi
coverslip
later
crush
bound
sequenc
elut
heat
water
select
aptam
amplifi
clone
sequenc
usual
dna
aptam
well
known
stabl
rna
aptam
allow
readili
use
primari
stage
develop
diagnost
tool
howev
degrad
dna
aptam
nucleas
still
seriou
problem
limit
clinic
applic
subject
complic
biolog
sampl
improv
nucleas
resist
dna
aptam
one
bind
neg
target
retain
amplifi
pcr
pcr
product
separ
ssdna
round
cycl
select
ssdna
clone
sequenc
aptam
identif
b
magneticassist
rapid
aptam
select
mara
targetco
magnet
bead
incub
ssdna
pool
bead
bound
sequenc
separ
unbound
sequenc
ushap
magnet
magnet
stand
redispers
bead
put
extern
appli
rotat
altern
magnet
field
process
weak
nonspecif
bind
sequenc
releas
separ
strongbind
sequenc
final
releas
bead
heat
incub
bead
without
target
neg
select
select
sequenc
amplifi
clone
sequenc
usual
c
onestep
select
famlabel
oligonucleotid
librari
incub
target
immobil
glass
coverslip
coat
nhydroxysuccinimid
nh
function
polyethylen
glycol
peg
unbound
sequenc
discard
extens
wash
follow
monitor
fluoresc
microscopi
coverslip
later
crush
bound
sequenc
elut
heat
water
select
aptam
amplifi
clone
sequenc
usual
dna
aptam
well
known
stabl
rna
aptam
allow
readili
use
primari
stage
develop
diagnost
tool
howev
degrad
dna
aptam
nucleas
still
seriou
problem
limit
clinic
applic
subject
complic
biolog
sampl
improv
nucleas
resist
dna
aptam
one
effect
solut
use
librari
chemic
modifi
dna
sequenc
screen
process
modifi
dna
librari
prepar
pcr
amplif
use
specif
polymeras
catalysi
reaction
use
modifi
dna
enzym
modif
aptam
also
perform
vitro
select
natur
nucleic
acid
librari
modif
sugar
phosphat
backbon
pyrimidin
strategi
use
increas
stabil
nucleas
resist
aptam
cap
end
aptam
also
util
enhanc
aptam
stabil
nucleas
incorpor
unnatur
nucleotid
anoth
approach
overcom
aptam
instabl
lock
nucleic
acid
lna
one
promin
success
nucleic
acid
analogu
pronounc
stabil
gener
mirror
aptam
also
known
spiegelm
anoth
approach
improv
aptam
stabil
nucleas
gener
highli
specif
aptam
long
lifetim
import
therapeut
applic
dna
aptam
small
molecular
weight
rang
kda
dna
aptam
readili
remov
via
renal
filtrat
metabol
process
limit
therapeut
applic
one
effect
way
control
lifetim
dna
aptam
vivo
conjug
aptam
bioavail
materi
conjug
dna
aptam
polyethylen
glycol
peg
commonli
use
prolong
circul
bloodstream
coat
dna
aptam
nanomateri
nanoparticl
liposom
copolym
success
use
improv
lifetim
dna
aptam
select
bind
diseaserel
biomark
pathogen
dna
aptam
develop
biosensor
chemic
modif
luminophor
linkag
nanoparticl
variou
format
exampl
earlier
studi
dna
aptam
select
bacillu
anthrac
spore
develop
detect
anthrax
spore
aptamermagnet
beadelectrochemiluminesc
amecl
sandwich
mode
dynal
magnet
bead
cover
aptam
use
captur
captur
spore
anoth
biotinyl
aptam
use
report
signal
final
transduc
streptavidinru
bpi
ecl
sinc
first
dna
aptam
select
dozen
dna
aptam
select
use
diseaserel
detect
although
aptamerbas
diagnost
tool
clinic
use
moment
mani
preclin
studi
indic
dna
aptam
great
potenti
use
way
profil
featur
recent
studi
use
dna
aptam
diagnost
tool
human
diseas
list
dna
aptam
select
purpos
tabl
special
attent
paramet
like
sensit
specif
great
impact
potenti
clinic
use
theori
aptam
select
develop
diagnost
tool
variou
diseas
long
definit
target
diseasespecif
biomark
pathogen
avail
date
dna
aptam
explor
mainli
diagnosi
infecti
diseas
cancer
cardiovascular
diseas
conveni
cellselex
requir
prepar
purif
target
molecul
mani
report
dna
aptam
select
cancer
cell
aim
diagnos
imag
cancer
tissu
cancer
cell
includ
pancreat
colon
liver
cholangio
gastric
prostat
breast
glioblastoma
cancer
cell
usual
select
consist
posit
select
cancer
cell
neg
select
normal
cell
organ
describ
section
worth
note
diagnosi
monitor
metastasi
cancer
cell
import
treatment
cancer
sever
dna
aptam
select
metastat
cancer
cell
neg
select
nonmetastat
cancer
cell
targetinduc
dissoci
aunp
n
amino
acid
ns
nonspecifi
exampl
li
et
al
select
dna
aptam
metastat
colon
cancer
cell
use
cell
deriv
metastat
site
lymph
node
posit
select
cell
primari
colon
adenocarcinoma
patient
neg
select
result
aptam
found
possess
specif
affin
metastat
colon
cancer
cell
k
nm
truncat
form
use
imag
cancer
tissu
label
fluorescein
amidit
fam
display
detect
rate
colon
cancer
tissu
metastasi
region
lymph
node
specif
nonmetastat
colon
cancer
tissu
biomark
molecul
specif
express
overexpress
cancer
cell
also
use
select
diagnost
dna
aptam
addit
previous
known
prostatespecif
membran
antigen
psma
mucin
biomark
like
epiderm
growth
factor
receptor
variant
iii
egfrviii
epitheli
cell
adhes
molecul
epcam
vascular
endotheli
growth
factor
also
use
select
dna
aptam
cancer
detect
directli
use
cancer
biomark
select
cancercellrecogn
aptam
obtain
highli
specif
affinit
aptam
potenti
risk
aptam
might
recogn
natur
biomark
surfac
cancer
cell
differ
structur
purifi
biomark
natur
biomark
diagnosi
infecti
agent
lot
dna
aptam
select
predominantli
cellselex
magnet
beadsbas
method
target
variou
virus
bacteria
antigen
protein
includ
target
noroviru
influenza
viru
sever
acut
respiratori
syndrom
coronaviru
sarscov
hepat
c
viru
hcv
hepat
b
viru
hbv
human
immunodefici
viru
hiv
human
papillomaviru
hpv
salmonella
typhimurium
pathogen
e
coli
low
cost
short
product
time
dna
aptam
dna
aptam
base
diagnost
tool
hold
particular
advantag
diagnosi
infect
need
pointofcar
test
infect
caus
highli
pathogen
pandem
influenza
viru
hiv
sarscov
malaria
avian
influenza
viru
highli
pathogen
subtyp
influenza
viru
also
infect
human
high
mortal
rate
wang
et
al
select
dna
aptam
target
use
viru
antigen
whole
viru
particl
use
selex
method
first
four
select
cycl
purifi
viru
antigen
hemagglutinin
ha
use
target
protein
remain
eight
cycl
entir
viru
particl
use
target
select
aptam
show
high
affin
k
nm
specif
viru
tabl
use
mix
select
mode
might
good
strategi
obtain
ideal
aptam
overcom
drawback
select
use
free
biomark
cell
case
cardiovascular
diseas
marker
blood
myoglobin
creactiv
protein
lhomocystein
thrombin
use
select
dna
aptam
diagnosi
relat
diseas
myoglobin
increas
acut
myocardi
infarct
import
earli
marker
urgent
diagnosi
cardiovascular
diseas
wang
et
al
select
dna
aptam
myoglobin
use
fluidic
chip
method
dna
aptam
lowest
k
valu
nm
subject
develop
differ
biosensor
detect
myoglobin
includ
myoglobininduc
structur
switch
supersandwich
biosensor
antibodymyoglobinaptam
sandwich
biosensor
human
creactiv
protein
crp
homopentamer
oligoprotein
valid
power
predictor
risk
factor
inflamm
cardiovascular
diseas
yang
et
al
select
dna
aptam
k
nm
target
crp
use
develop
sensor
base
surfac
plasmon
reson
technolog
lhomocystein
amino
acid
intermedi
whose
elev
level
blood
associ
coronari
heart
diseas
mckeagu
et
al
select
dna
aptam
target
lhomocystein
develop
aptameraunp
sensor
dna
aptam
first
coil
around
surfac
gold
particl
releas
particl
bind
homocystein
lead
saltinduc
aggreg
color
particl
thrombin
serin
proteas
play
critic
role
format
obstruct
blood
clot
thrombosi
involv
variou
diseas
includ
chronic
cardiovascular
diseas
first
report
dna
aptam
thrombin
aptam
sinc
thrombin
aptam
use
model
aptam
explor
mode
aptamerbas
biosensor
frequent
use
dna
aptam
demonstr
proofofprincipl
variou
detect
method
gener
modal
assay
format
use
aptam
sensor
well
summar
mani
comprehens
review
roughli
classifi
four
type
base
way
signal
gener
direct
bindingbas
mode
targetinduc
structur
switch
mode
sandwichlik
mode
targetinduc
assembl
dissoci
mode
protocol
illustr
figur
direct
bindingbas
mode
figur
aptam
label
signal
molecul
directli
bind
target
signal
molecul
aptamerbound
target
detect
directli
aptam
cancer
cell
imag
usual
use
mode
tabl
simpl
direct
mode
especi
suitabl
situat
like
vivo
imag
allow
complex
detect
contain
signal
amplif
make
difficult
increas
detect
sensit
targetinduc
structur
switch
mode
bind
target
caus
specif
conform
chang
aptam
switch
switch
signal
gener
exampl
biochromophor
targetinduc
structur
switch
approach
fluorophorelabel
dna
aptam
form
partial
duplex
small
oligonucleotid
modifi
quench
moieti
denot
qdna
absenc
target
bring
fluorophor
f
quencher
q
close
proxim
maximum
fluoresc
quench
target
introduc
aptam
prefer
form
aptamertarget
complex
bind
target
aptam
chang
structur
aptam
releas
partial
complementari
quencher
trigger
increas
signal
figur
mode
suit
develop
aptamerbas
report
realtim
sens
applic
limit
mode
decreas
aptam
bind
affin
competit
qdna
sandwichlik
mode
target
meat
insert
within
two
piec
bread
consist
aptameraptam
antibodyaptam
similar
enzymelink
immunosorb
assay
elisa
figur
aptam
mode
function
report
andor
captur
method
permit
doubl
recognit
target
signal
amplif
greatli
improv
specif
sensit
aptamerbas
detect
moreov
small
size
aptam
aptam
sandwich
mode
conquer
potenti
limit
antibodi
elisa
detect
small
molecul
mode
requir
extens
wash
detect
targetinduc
assembl
dissoci
mode
bind
target
aptam
trigger
assembl
split
aptam
dissoci
bound
aptam
along
chang
detect
signal
figur
addit
note
variou
detect
method
appli
dna
aptam
base
biosensor
includ
electrochem
chemiluminesc
fluoresc
colorimetr
quantum
dotsbas
masssensit
detect
imag
cancer
cell
dna
aptam
base
method
use
fluorophorelabel
aptam
recogn
cancer
cell
directli
tabl
small
target
like
microorgan
marker
protein
method
base
differ
mode
explor
extens
sandwichlik
mode
frequent
use
figur
exampl
leishmania
detect
aptam
target
promastigot
leishmania
immobil
surfac
magnet
bead
target
leishmania
promastigot
captur
anoth
biotinyl
report
aptam
target
hydrophil
surfac
protein
hsp
leishmania
promastigot
ad
bead
aptamercaptur
leishmania
promastigot
report
collect
magnet
rack
streptavidinhorseradish
peroxidas
savhrp
substrat
ampl
red
ad
transduc
display
signal
anoth
frequent
use
mode
targetinduc
dissoci
mode
system
nonsign
statu
singlestrand
aptam
dissoci
initi
state
result
bind
target
detect
lhomocystein
mention
good
exampl
targetinduc
dissoci
mode
figur
dna
aptam
coil
around
surfac
gold
nanoparticl
aunp
prevent
saltinduc
aggreg
aunp
target
molecul
appear
dna
aptam
fold
rigid
structur
bind
target
therefor
releas
aunp
aunp
without
coverag
aptam
aggreg
salt
solut
chang
color
red
purpl
signalmoleculelabel
aptam
directli
bind
immobil
free
target
signal
molecul
target
detect
directli
b
targetinduc
structur
switch
mode
fluorophorelabel
dna
aptam
form
partial
duplex
small
oligonucleotid
modifi
quench
moieti
qdna
absenc
target
bring
fluorophor
f
quencher
q
close
proxim
maximum
fluoresc
quench
target
introduc
aptam
prefer
form
aptamertarget
complex
bind
target
aptam
chang
structur
aptam
releas
partial
complementari
quencher
trigger
increas
signal
c
sandwichlik
mode
aptam
antibodi
immobil
solid
phase
captur
captur
target
report
biotinyl
aptam
display
signal
bind
streptavidinconjug
hrp
aunp
targetinduc
dissoci
mode
dna
aptam
coil
around
surfac
gold
nanoparticl
aunp
stop
saltinduc
aggreg
aunp
target
appear
dna
aptam
bind
target
releas
aunp
aunp
without
cover
aptam
aggreg
salt
solut
chang
color
red
purpl
one
biggest
challeng
aptamerbas
diagnost
tool
clinic
use
possibl
invalid
real
biolog
environ
result
degrad
nucleas
interfer
matrix
factor
use
chemic
modifi
dna
aptam
effect
way
prolong
lifetim
dna
aptam
biolog
sampl
ultim
success
suffici
studi
clinic
sampl
vivo
studi
indispens
current
although
studi
dna
aptam
base
diagnost
tool
human
diseas
still
primari
stage
laboratori
studi
gone
test
clinic
sampl
anim
studi
vivo
dna
aptam
tabl
target
pancreat
ductal
adenocarcinoma
pdac
cell
test
clinic
pdac
tissu
section
vivo
imag
pdac
tumorbear
mice
pdac
tissu
two
eight
normal
pancreat
tissu
detect
vivo
imag
test
inject
balbcnud
mice
graft
pdac
tail
vein
found
illumin
tumor
site
h
postinject
librari
control
give
signal
studi
phosphorothio
modif
tri
dna
aptam
four
base
termini
replac
ether
phosphorothio
oligonucleotid
oligonucleotid
howev
phosphorothio
modif
signalmoleculelabel
aptam
directli
bind
immobil
free
target
signal
molecul
target
detect
directli
b
targetinduc
structur
switch
mode
fluorophorelabel
dna
aptam
form
partial
duplex
small
oligonucleotid
modifi
quench
moieti
qdna
absenc
target
bring
fluorophor
f
quencher
q
close
proxim
maximum
fluoresc
quench
target
introduc
aptam
prefer
form
aptamertarget
complex
bind
target
aptam
chang
structur
aptam
releas
partial
complementari
quencher
trigger
increas
signal
c
sandwichlik
mode
aptam
antibodi
immobil
solid
phase
captur
captur
target
report
biotinyl
aptam
display
signal
bind
streptavidinconjug
hrp
aunp
targetinduc
dissoci
mode
dna
aptam
coil
around
surfac
gold
nanoparticl
aunp
stop
saltinduc
aggreg
aunp
target
appear
dna
aptam
bind
target
releas
aunp
aunp
without
cover
aptam
aggreg
salt
solut
chang
color
red
purpl
one
biggest
challeng
aptamerbas
diagnost
tool
clinic
use
possibl
invalid
real
biolog
environ
result
degrad
nucleas
interfer
matrix
factor
use
chemic
modifi
dna
aptam
effect
way
prolong
lifetim
dna
aptam
biolog
sampl
ultim
success
suffici
studi
clinic
sampl
vivo
studi
indispens
current
although
studi
dna
aptam
base
diagnost
tool
human
diseas
still
primari
stage
laboratori
studi
gone
test
clinic
sampl
anim
studi
vivo
dna
aptam
tabl
target
pancreat
ductal
adenocarcinoma
pdac
cell
test
clinic
pdac
tissu
section
vivo
imag
pdac
tumorbear
mice
pdac
tissu
two
eight
normal
pancreat
tissu
detect
vivo
imag
test
inject
balbcnud
mice
graft
pdac
tail
vein
found
illumin
tumor
site
h
postinject
librari
control
give
signal
studi
phosphorothio
omethyl
modif
tri
dna
aptam
four
base
termini
replac
ether
phosphorothio
oligonucleotid
omethyl
oligonucleotid
howev
phosphorothio
modif
found
weaken
bind
abil
aptam
wherea
omethyl
modif
significantli
affect
bind
abil
moreov
omethyl
modifi
could
last
h
fb
medium
unmodifi
complet
degrad
incub
import
applic
aptam
use
smallmolecul
therapeut
agent
dna
aptam
exhibit
signific
advantag
therapeut
applic
develop
attract
therapeut
agent
competit
antibodi
gener
dna
aptam
use
therapeut
applic
function
two
way
first
dna
aptam
inhibit
proteinprotein
interact
specif
bind
target
protein
therebi
function
antagonist
second
dna
aptam
function
agonist
promot
function
target
protein
upon
bind
target
protein
although
dna
aptam
act
similarli
antibodi
nonimmunogen
dna
aptam
make
notabl
therapeut
compar
antibodi
dna
aptam
easier
uptak
small
size
importantli
aptam
specif
recogn
wide
rang
target
includ
small
molecul
protein
cell
moreov
given
dna
aptam
design
select
vitro
lower
product
cost
antibodi
properti
advantag
dna
aptam
mention
facilit
promis
applic
dna
aptam
field
therapeut
although
current
dna
aptam
therapeut
clinic
use
four
dna
aptam
evalu
clinic
trial
effect
hematolog
diseas
macular
degener
diseas
cancer
tabl
antisoma
guaninerich
aptam
guanin
quadruplex
structur
target
nucleolin
nucleolin
eukaryot
nucleolar
phosphoprotein
involv
synthesi
matur
ribosom
report
target
anticanc
therapi
guanin
quadruplex
structur
help
enhanc
nucleas
degrad
resist
cell
uptak
possess
anticanc
activ
breast
cancer
cell
metastat
renal
cell
carcinoma
acut
myeloid
leukemia
phase
clinic
trial
use
treat
renal
cell
carcinoma
complet
anoth
phase
clinic
trial
treat
acut
myeloid
leukemia
complet
achemix
pegyl
dna
aptam
recogn
platelet
ligand
receptor
von
willebrand
factor
mediat
platelet
recruit
block
bind
von
willebrand
factor
platelet
therebi
induc
antithrombot
effect
efficaci
platelet
inhibit
demonstr
phase
clinic
trial
treat
von
willebrand
factor
relat
platelet
function
disord
complet
recent
studi
show
effect
prevent
thromboembol
phase
clinic
studi
show
exhibit
favor
pharmacokinet
pharmacodynam
safeti
properti
patient
congenit
thrombot
thrombocytopen
purpura
arca
biopharma
unmodifi
dna
aptam
target
thrombin
prolong
blood
clot
phase
clinic
trial
use
anticoagul
agent
patient
undergo
offpump
coronari
arteri
bypass
graft
cabg
surgeri
snapcabgoff
complet
ophthotech
pegyl
dna
aptam
function
antagonist
plateletderiv
growth
factor
combin
antivegf
agent
effect
prevent
angiogenesi
current
phase
clinic
studi
combin
ranibizumab
lucenti
wet
agerel
macular
degener
treatment
ongo
besid
dna
aptam
clinic
trial
mani
promis
dna
aptam
preclin
studi
treat
variou
diseas
viru
infect
tumor
central
nervou
system
diseas
dna
aptam
recogn
receptorbind
region
influenza
hemagglutinin
found
inhibit
viral
infect
anim
model
differ
influenza
strain
manifest
reduct
viru
burden
lung
treat
mice
dna
aptam
found
bind
vimentin
caus
apoptosi
mous
ascit
adenocarcinoma
cell
vitro
vivo
recent
dna
aptam
target
human
epiderm
growth
factor
receptor
demonstr
retard
tumorigen
growth
gastric
cancer
mice
effect
activ
monoclon
antibodi
moreov
remyelin
induc
dna
aptam
mous
model
multipl
sclerosi
inflammatori
diseas
central
nervou
system
highlight
potenti
therapeut
applic
dna
aptam
treatment
multipl
sclerosi
cellspecif
drug
deliveri
help
increas
effici
drug
reduc
side
effect
addit
function
therapeut
agent
dna
aptam
also
explor
deliveri
vehicl
target
deliveri
drug
small
oligonucleotid
small
interfer
rna
sirna
microrna
mirna
abil
aptam
specif
recogn
target
readili
modifi
make
potenti
target
deliveri
tool
dna
aptam
use
two
way
target
deliveri
drug
directli
link
drug
molecul
combin
nanoparticl
form
deliveri
platform
conjug
drug
molecul
directli
specif
dna
aptam
potenti
way
deliv
drug
specif
thu
reduc
risk
offtarget
drug
link
dna
aptam
drug
pack
drug
aptamerfold
structur
dna
aptamersdrug
conjug
effici
deliv
drug
target
cell
increas
specif
mani
dna
aptam
select
effici
deliv
chemotherapi
drug
vitro
vivo
doxorubicin
dox
fluorouracil
epirubicin
dimer
dendrim
dna
aptam
conjug
drug
develop
enhanc
effici
target
deliveri
regard
small
oligonucleotid
deliveri
dna
aptam
directli
link
small
oligonucleotid
form
dna
aptameroligonucleotid
chimera
could
help
prevent
nonspecif
intern
well
decreas
cellular
toxic
toward
nontarget
cell
report
dna
aptamersirna
chimera
could
specif
enter
cell
effici
decreas
express
exogen
hiv
proteas
gene
antimucin
dna
aptam
coval
link
found
deliv
ovarian
cancer
cell
specif
induc
signific
apoptosi
cancer
cell
dna
aptam
combin
nanoparticl
deliveri
vehicl
anoth
promis
target
deliveri
approach
number
nanomateri
explor
conjug
dna
aptam
form
deliveri
platform
dna
aptam
conjug
liposom
like
highest
potenti
deliveri
system
liposomebas
drug
deliveri
system
evalu
clinic
trial
exampl
aptam
conjug
liposom
found
abl
enhanc
deliveri
specif
uptak
dox
tumor
cell
well
increas
accumul
dox
tumor
tissu
reduc
cardiotox
vivo
micel
aggreg
lipid
molecul
also
use
dna
aptamernanoparticl
deliveri
system
recent
aptam
conjug
pegpoli
lacticcoglycol
acid
plga
nanoparticl
develop
facilit
antiglioma
deliveri
paclitaxel
vivo
aptamerpegplga
deliveri
system
prolong
circul
time
enhanc
target
accumul
paclitaxel
facilit
tumor
inhibit
gold
nanoparticl
anoth
attract
materi
use
drug
deliveri
system
high
stabil
low
toxic
facil
conjug
dna
aptam
conjug
gold
nanoparticl
system
found
increas
uptak
dox
cancer
cell
nanomateri
silica
carbon
nanotub
quantum
dot
also
use
dna
aptamernanoparticl
deliveri
system
enhanc
specif
prolong
circul
drug
molecul
summar
progress
gener
dna
aptam
applic
human
diseas
diagnosi
therapi
shown
dna
aptam
great
potenti
use
altern
antibodi
sinc
first
monoclon
antibodi
produc
antibodi
success
extens
use
diagnosi
therapi
human
diseas
aptam
expect
achiev
similar
success
antibodi
stabil
low
cost
facil
manipul
dna
aptam
continu
extens
studi
appli
although
modifi
rna
aptam
enhanc
stabil
high
cost
chemic
modifi
rna
might
limit
studi
applic
howev
rna
aptam
hold
advantag
provid
complex
divers
structur
help
select
aptam
high
affin
complex
target
need
diseas
therapi
therefor
dna
aptam
might
promis
applic
diagnosi
vivo
imag
modifi
rna
aptam
might
promis
applic
therapi
era
person
medicin
dna
aptamerbas
therapeut
diagnost
believ
great
potenti
extens
applic
flexibl
specif
bind
molecul
target
wide
appli
still
mani
problem
remain
address
problem
like
nucleas
degrad
quick
renal
excret
potenti
crossreact
aptam
analyz
futur
studi
